Proposed Registration Decision PRD2021-02, Picarbutrazox and VAYANTIS Seed Treatment
This summary describes the key points of the evaluation, while the Science Evaluation of Proposed Registration Decision PRD2021-02, Picarbutrazox and VAYANTIS Seed Treatment provides detailed technical information on the human health, environmental and value assessments of picarbutrazox and VAYANTIS Seed Treatment.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-03-29
Data overview
- Formats
- HTML
- File languages
- English, French